Actively Recruiting
Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With Obesity
Led by Université Catholique de Louvain · Updated on 2026-05-14
100
Participants Needed
1
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
As with other nutritional strategies, the clinical response to bariatric surgery can be highly variable, with weight regain being a frequent occurrence. Recent evidence on anti-obesity medication indicate similar inter-individual variability in clinical response. Among multiples factors, co-occurrence of eating disorders such as binge eating disorder has been implicated in insufficient clinical response. Improving our ability to predict how patients will respond to obesity treatment is necessary in order to tailor the care pathways we offer. The mechanisms involved in disturbances of eating behaviour before and after surgery remain largely unknown. This study aims to identify the predictive factors of weight loss after pharmacological or surgical treatment, as well as the cognitive and biological mechanisms that mediate this effect.
CONDITIONS
Official Title
Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With Obesity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Obesity, with bariatric surgery indicated after a multidisciplinary evaluation in case of surgical treatment
- Good physical and mental health, enabling informed consent
- French speaker
You will not qualify if you...
- Under legal protection
- Pregnant or breastfeeding
- History of bariatric surgery (except gastric banding removed more than five years ago)
- Acute or progressive chronic disease
- Alcohol consumption of more than 20 g/day
- Inflammatory bowel disease
- Digestive autonomic diabetic neuropathy
- Use of dietary supplements such as stanols, probiotics, prebiotics, or omega-3
- Following a vegan or gluten-free diet or being lactose intolerant
- Fiber consumption greater than 30 g/day
- Recent change in antidiabetic medication within the past 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, Belgium, 1200
Actively Recruiting
Research Team
P
Pr Amandine Everard, Professor
CONTACT
Y
Yannick Deswysen, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here